1
|
Ruseckaite R, Mudunna C, Caruso M, Ahern S. Response rates in clinical quality registries and databases that collect patient reported outcome measures: a scoping review. Health Qual Life Outcomes 2023; 21:71. [PMID: 37434146 DOI: 10.1186/s12955-023-02155-5] [Citation(s) in RCA: 6] [Impact Index Per Article: 6.0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/14/2023] [Accepted: 06/26/2023] [Indexed: 07/13/2023] Open
Abstract
BACKGROUND Patient Reported Outcome Measures (PROMs) are being increasingly introduced in clinical registries, providing a personal perspective on the expectations and impact of treatment. The aim of this study was to describe response rates (RR) to PROMs in clinical registries and databases and to examine the trends over time, and how they change with the registry type, region and disease or condition captured. METHODS We conducted a scoping literature review of MEDLINE and EMBASE databases, in addition to Google Scholar and grey literature. All English studies on clinical registries capturing PROMs at one or more time points were included. Follow up time points were defined as follows: baseline (if available), < 1 year, 1 to < 2 years, 2 to < 5 years, 5 to < 10 years and 10 + years. Registries were grouped according to regions of the world and health conditions. Subgroup analyses were conducted to identify trends in RRs over time. These included calculating average RRs, standard deviation and change in RRs according to total follow up time. RESULTS The search strategy yielded 1,767 publications. Combined with 20 reports and four websites, a total of 141 sources were used in the data extraction and analysis process. Following the data extraction, 121 registries capturing PROMs were identified. The overall average RR at baseline started at 71% and decreased to 56% at 10 + year at follow up. The highest average baseline RR of 99% was observed in Asian registries and in registries capturing data on chronic conditions (85%). Overall, the average RR declined as follow up time increased. CONCLUSION A large variation and downward trend in PROMs RRs was observed in most of the registries identified in our review. Formal recommendations are required for consistent collection, follow up and reporting of PROMs data in a registry setting to improve patient care and clinical practice. Further research studies are needed to determine acceptable RRs for PROMs captured in clinical registries.
Collapse
Affiliation(s)
- Rasa Ruseckaite
- School of Public Health and Preventive Medicine, Monash University, Melbourne, Victoria, 3004, Australia.
| | - Chethana Mudunna
- School of Public Health and Preventive Medicine, Monash University, Melbourne, Victoria, 3004, Australia
| | - Marisa Caruso
- School of Public Health and Preventive Medicine, Monash University, Melbourne, Victoria, 3004, Australia
| | - Susannah Ahern
- School of Public Health and Preventive Medicine, Monash University, Melbourne, Victoria, 3004, Australia
| |
Collapse
|
2
|
Khandwala YS, Ohanian A, Huang FW. Prostate Cancer in the Caribbean: A Baseline Assessment of Current Practices and Potential Needs. Cancer Control 2022. [PMCID: PMC8961354 DOI: 10.1177/10732748221082372] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/27/2022] Open
Abstract
Afro-Caribbean men have a higher risk of prostate cancer than any other population of men
in the world. However, the Caribbean is composed of a heterogenous group of healthcare
systems located on small islands which makes population-based studies difficult to conduct
and interpret. The aim of this review is to compile previously published data on the state
of prostate cancer in Caribbean men and to highlight potential healthcare needs that can
be addressed by public health efforts. We reviewed three databases and identified relevant
papers that were subsequently searched by the authors. Peer-reviewed studies published in
the English language after 2010 with a focus on prostate cancer diagnosis, management, and
outcomes of Caribbean men were prioritized. Afro-Caribbean men were found to have a higher
incidence and mortality rate compared to their counterparts. Misperception about the
disease, lack of regional guidelines, and poor access to care are compounding factors that
result in worse outcomes for these men compared to high-income nations. Urologists and
oncologists in the region, while well-trained, are limited in number and in most cases do
not offer newer treatment modalities. Overall, only a few island nations have cancer
registries, and there remains a significant need for more population-based studies to
assess guideline adherence and outcomes. Until further research and investment in the
region is made, the disparity between the care received by Afro-Caribbean men and their
counterparts will likely remain.
Collapse
Affiliation(s)
- Yash S Khandwala
- Department of Urology, Stanford University Medical Center, Stanford, CA, USA
| | - Alec Ohanian
- Division of Hematology and Oncology, University of California, San Francisco, CA, USA
| | - Franklin W Huang
- Division of Hematology and Oncology, University of California, San Francisco, CA, USA
| |
Collapse
|
3
|
Badal K, Moore M, Thomas M. The Repository for Caribbean Cancer Publications (ReCCaP): Database Development and Publication Trends 2004-2019. Cancer Manag Res 2021; 13:5433-5442. [PMID: 34262351 PMCID: PMC8275050 DOI: 10.2147/cmar.s314853] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/17/2021] [Accepted: 06/16/2021] [Indexed: 12/03/2022] Open
Abstract
Objective In the Caribbean region, research has been limited, making it challenging to find. In order for the region to optimally access and utilize present research and identify gaps, we developed the Repository for Caribbean Cancer Publications (ReCCaP) to home publications on cancer in the Caribbean population and diaspora and report on publication trends. Methods A systematic PubMed literature search for the period 2004–2019 (15 years) was developed using keywords related to “cancer” and “Caribbean.” Three independent investigators verified included publications. The final database was formatted and hosted in an online database management software. Publication trends over time, by country, cancer type, and income classification were investigated. Results Of the 4935 publications found, 1194 papers met the inclusion criteria with 803 publications (67.25%) being on the Caribbean population, 139 publications (11.64%) including multiple Caribbean countries and 252 publications (21.11%) on the diaspora. Between 2004 and 2019, there was an overall 0.20 increase in publications regionally. Overall, most publications were on breast (n = 168, 14.07%), prostate (n = 156, 13.07%), cervical (n = 152, 12.73%), colorectal (n = 80, 6.70%), and lung cancer (n = 36, 3.02%). The highest number of papers were published by Puerto Rico (22.80 pubs/year), Cuba (8.27 pubs/year), Jamaica (6.27 pubs/year), Trinidad and Tobago (3.53 pubs/year), and Martinique (2.27 pubs/year). The high-income countries (n=10) collectively lead in publications over the 15-year period. Conclusion ReCCaP provides an easily searchable database highlighting published work and gaps in knowledge on cancer in the Caribbean and diaspora.
Collapse
Affiliation(s)
- Kimberly Badal
- Caribbean Cancer Research Initiative, Port of Spain, Trinidad and Tobago
| | - Moesha Moore
- Caribbean Cancer Research Initiative, Port of Spain, Trinidad and Tobago
| | - Mikhail Thomas
- Caribbean Cancer Research Initiative, Port of Spain, Trinidad and Tobago
| |
Collapse
|
4
|
Joachim C, Veronique-Baudin J, Vinh-Hung V, Contaret C, Macni J, Godaert L, Escarmant P, Farid K, Novella JL, Drame M, Tortolero-Luna G, Babie PT, Zavala DE, Alvarez YG. Building capacity for cancer surveillance and public health research: The Cancer Task Force Project for Cooperation in the Caribbean and Aging Research. J Glob Health 2020; 9:020304. [PMID: 31360443 PMCID: PMC6642813 DOI: 10.7189/jogh.09.020304] [Citation(s) in RCA: 4] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/30/2022] Open
Affiliation(s)
- Clarisse Joachim
- UF1441 Registre des cancers de la Martinique, Pôle de Cancérologie Hématologie Urologie, CHU Martinique, Fort-de-France, Martinique
| | - Jacqueline Veronique-Baudin
- UF1441 Registre des cancers de la Martinique, Pôle de Cancérologie Hématologie Urologie, CHU Martinique, Fort-de-France, Martinique
| | - Vincent Vinh-Hung
- Pôle de Cancérologie Hématologie Urologie, CHU Martinique, Fort-de-France, Martinique
| | - Cédric Contaret
- UF 3163, Délégation de la Recherche et de l'innovation, CHU de Martinique, Martinique
| | - Jonathan Macni
- UF1441 Registre des cancers de la Martinique, Pôle de Cancérologie Hématologie Urologie, CHU Martinique, Fort-de-France, Martinique
| | - Lidvine Godaert
- Pôle de Gériatrie, CHU de Martinique, Fort-de-France, Martinique
| | - Patrick Escarmant
- Pôle de Cancérologie Hématologie Urologie, CHU Martinique, Fort-de-France, Martinique
| | - Karim Farid
- Pole d'imagerie Médicale Service de Médecine nucléaire, CHU Martinique, Martinique
| | - Jean-Luc Novella
- Faculté de Médecine, EA 3797, Université de Reims Champagne- Ardenne, Reims, France.,Département de Médecine Interne et Gériatrie, CHU de Reims, Reims, France
| | - Moustapha Drame
- Faculté de Médecine, EA 3797, Université de Reims Champagne- Ardenne, Reims, France.,Unité d'aide Méthodologique, Pôle Recherche et Santé publique, CHU de Reims, Reims, France
| | - Guillermo Tortolero-Luna
- University of Puerto Rico, San Juan, Puerto Rico.,Puerto Rico Central Cancer Registry, Comprehensive Cancer Center, San Juan, Puerto Rico
| | | | - Diego E Zavala
- University of Puerto Rico, San Juan, Puerto Rico.,Puerto Rico Central Cancer Registry, Comprehensive Cancer Center, San Juan, Puerto Rico
| | - Yaima Galan Alvarez
- Registro Nacional de Cáncer de Cuba, Sección Independiente para el Control del Cáncer, Instituto Nacional de Oncología y Radiobiología, Habana, Cuba
| |
Collapse
|
5
|
Joachim C, Ulric-Gervaise S, Dramé M, Macni J, Escarmant P, Véronique-Baudin J, Vinh-Hung V. Long-term survival of patients with prostate cancer in Martinique: Results of a population-based study. Cancer Epidemiol 2019; 59:193-198. [PMID: 30825842 DOI: 10.1016/j.canep.2019.02.007] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/14/2018] [Revised: 02/04/2019] [Accepted: 02/08/2019] [Indexed: 12/27/2022]
Abstract
BACKGROUND Martinique has one of the highest incidences of prostate cancer (PCa) worldwide. We analysed overall survival (OS) among patients with PCa in Martinique, using data from a population-based cancer registry between 2005 and 2014. METHODS The log-rank test was used to assess the statistical differences between survival curves according to age at diagnosis, risk of disease progression including Gleason score, stage at diagnosis and Prostate Specific Antigen (PSA). A multivariable Cox model was constructed to identify independent prognostic factors for OS. RESULTS A total of 5045 patients were included with a mean age at diagnosis of 68.1±9.0 years [36.0 - 98.0 years]. Clinical stage was analysed in 4999 (99.1% of overall), 19.5% were at low risk, 34.7% intermediate and 36.9% at high risk. In our study, 8.9% of patients with available stage at diagnosis, were regional/metastatic cancers. Median PSA level at diagnosis was 10.4 ng/mL. High-risk PCa was more frequent in patients aged 65-74 and ≥75 years as compared to those aged <65 years (36.6% and 48.8% versus 28.7% respectively; p<0.0001). One-year OS was 96.3%, 5-year OS was 83.4 and 10-year OS was 65.0%. Median survival was not reached in the whole cohort. High-risk PCa (HR=2.32; p<0.0001), regional/metastatic stage (HR= 9.51; p<0.0001) and older age (65-74 and ≥75 years - respectively HR=1.70; and HR=3.38), were independent prognostic factors for OS (p<0.0001). CONCLUSION This study provides long term data that may be useful in making cancer management decisions for patients with PCa in Martinique.
Collapse
Affiliation(s)
- Clarisse Joachim
- UF 1441 Registre Général des cancers de la Martinique, Pôle de Cancérologie Hématologie Urologie Pathologie, CHU de Martinique, 97200, Fort-de-France, Martinique.
| | - Stephen Ulric-Gervaise
- UF 1441 Registre Général des cancers de la Martinique, Pôle de Cancérologie Hématologie Urologie Pathologie, CHU de Martinique, 97200, Fort-de-France, Martinique
| | - Moustapha Dramé
- UF 3163, Unité de soutien méthodologique à la Recherche, Délégation de la Recherche et de l'innovation, CHU Martinique, 97200, Fort-de-France, Martinique
| | - Jonathan Macni
- UF 1441 Registre Général des cancers de la Martinique, Pôle de Cancérologie Hématologie Urologie Pathologie, CHU de Martinique, 97200, Fort-de-France, Martinique
| | - Patrick Escarmant
- Pôle de Cancérologie Hématologie Urologie Pathologie, CHU de Martinique, 97200, Fort-de-France, Martinique
| | - Jacqueline Véronique-Baudin
- UF 1441 Registre Général des cancers de la Martinique, Pôle de Cancérologie Hématologie Urologie Pathologie, CHU de Martinique, 97200, Fort-de-France, Martinique
| | - Vincent Vinh-Hung
- Pôle de Cancérologie Hématologie Urologie Pathologie, CHU de Martinique, 97200, Fort-de-France, Martinique
| |
Collapse
|